Smart diet plan uses glucose monitors to help asian americans tame diabetes

NCT ID NCT07278531

First seen Jan 05, 2026 · Last updated Jun 20, 2026 · Updated 27 times

Summary

This study tests whether a personalized diet plan, guided by a continuous glucose monitor (CGM), can help Chinese and Vietnamese Americans with type 2 diabetes better control their blood sugar. 120 participants will either receive the adaptive diet program or standard care for 12 weeks, followed by 12 weeks of follow-up. The program starts with just the CGM, and if blood sugar doesn't improve, adds culturally tailored dietary coaching.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NYU Langone Health

    New York, New York, 10016, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Continuous glucose monitor and personalized dietary advice

What this could lead to

If successful, this approach could offer a practical, culturally tailored way for Asian Americans with type 2 diabetes to better manage their blood sugar without extra medication.

What could go wrong

This is a small, early feasibility study (120 people) that primarily measures recruitment and retention, not long-term health outcomes. The intervention is complex and may not work for everyone.

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.